Diagnostic Report: Final

DIAGNOSTIC REPORT
Patient Ref. No. 323000001124697
CLIENT CODE : C000137711
CLIENT'S NAME AND ADDRESS :

RAGHA DIAGNOSTICS CENTRE
THULIR MULTISPECIALITY CLINIC, NO-3 MAKKARAM GARDEN, Veda Ranghaa Nivas, No:22/97,Dr.Ambedkar Road, Ashok Nagar,4th
TIRUVALLUR Avenue
TIRUVALLUR 600099 CHENNAI, 600083
TAMIL NADU INDIA TAMIL NADU, INDIA
6382369989
PATIENT NAME : MRS.SHANMUGAPRIYA P PATIENT ID : MRSSF240979323
ACCESSION NO : 0323VI006981 AGE : 43 Years SEX : Female
DRAWN : 24/09/2022 00:00 RECEIVED : 24/09/2022 12:20 REPORTED : 24/09/2022 16:21
REFERRING DOCTOR : DR. DR P RAJA MD CLIENT PATIENT ID :
Test Report Status Final Results Biological Reference Interval Units
EIA - AUTO IMMUNE

ANTI - CCP ANTIBODIES, SERUM
ANTI - CCP ANTIBODIES <7.00 < or = 17.00 U/mL
Interpretation(s)
ANTI - CCP ANTIBODIES, SERUM-Rheumatoid arthritis (RA) is a systematic autoimmune disease that is multi-functional in origin and is characterized by chronic
inflammation of the membrane lining(synovium) joints which commonly leads to progressive joint destruction and in most cases to disability and reduction of quality of life..
The disease spreads from small to large joints, with the greatest damage in early phase.
The diagnosis of RA is primarily based on clinical, radiological and immunological features. The most frequent serological test is the measurement of rheumatoid factor (RF).
The IgM class is the most common and is found in 60-80% of RA patients. RF is not specific for RA, as it is often present in healthy individuals and patients with other
autoimmune diseases and chronic infections. Citrullinated proteins have been discovered in the joints of patients with rheumatoid arthritis but not in other forms of joint
disease. The citrullinated proteins in the joints correspond to the presence of the citrulline antibodies in the blood and suggest a possible role for these antibodies in the
development of rheumatoid arthritis. Anti-CCP test is used for the detection of the IgG class of autoantibodies specific to cyclic citrullinated peptide (CCP) in human serum or
plasma (EDTA). Autoantibody levels represent one parameter in a multi-criterion diagnosis process, encompassing both clinical and laboratory-based assessments.
The citrulline antibody appears early in the course of rheumatoid arthritis and is present in the blood of most patients with the disease. When the citrulline antibody is
detected in a patient''s blood, there is 90-95% likelihood that the patient has rheumatoid arthritis. The test for the citrulline antibody is therefore useful in the diagnosis of
patients with unexplained joint inflammation, especially when the traditional blood test for rheumatoid factor is negative. The citrulline antibody also has prognostic
(predictive) value since it is associated with a greater tendency towards more destructive forms of rheumatoid arthritis.
Detection of anti -CCP antibodies is used as an aid in the diagnosis of Rheumatoid arthritis(RA) and should be used in conjunction with other clinical information.
AUTOIMMUNE IFA
ABS TO EXTRACTABLE NUCLEAR ANTIGEN(ANA BLOT),SERUM
SMITH ANTIBODIES NEGATIVE (0)

U1 SM/RNP ANTIBODIES NEGATIVE (0)
SS-A ANTIBODIES NEGATIVE (0)
RO-52 ANTIBODIES NEGATIVE (0)
SS-B ANTIBODIES NEGATIVE (0)
DSDNA NEGATIVE (0)
ANTI HISTONES ANTIBODIES NEGATIVE (0)
ANTI CENTROMERE ANTIBODIES NEGATIVE (0)
SCL-70 IGG ANTIBODIES NEGATIVE (0)
PM-SCL ANTIBODIES NEGATIVE (0)
JO-1 ABS IMMUNOBLOT NEGATIVE (0)
PCNA ANTIBODIES NEGATIVE (0)
NUCLEOSOME ANTIBODIES NEGATIVE (0)
AMA-M2 ANTIBODIES NEGATIVE (0)
RIBOSOMAL P ANTIBODIES NEGATIVE (0)
Page 1 Of 2
Scan to View Details Scan to View Report

DIAGNOSTIC REPORT
Patient Ref. No. 323000001124697
CLIENT CODE : C000137711
CLIENT'S NAME AND ADDRESS :

RAGHA DIAGNOSTICS CENTRE
THULIR MULTISPECIALITY CLINIC, NO-3 MAKKARAM GARDEN, Veda Ranghaa Nivas, No:22/97,Dr.Ambedkar Road, Ashok Nagar,4th
TIRUVALLUR Avenue
TIRUVALLUR 600099 CHENNAI, 600083
TAMIL NADU INDIA TAMIL NADU, INDIA
6382369989
PATIENT NAME : MRS.SHANMUGAPRIYA P PATIENT ID : MRSSF240979323
ACCESSION NO : 0323VI006981 AGE : 43 Years SEX : Female
DRAWN : 24/09/2022 00:00 RECEIVED : 24/09/2022 12:20 REPORTED : 24/09/2022 16:21
REFERRING DOCTOR : DR. DR P RAJA MD CLIENT PATIENT ID :
Test Report Status Final Results Biological Reference Interval Units
ANTI-MI-2 NEGATIVE (0)

ANTI-KU NEGATIVE (0)
Comments
If the ANA IFA is POSITIVE and the ANA Immunoblot specific antibody test(s) are negative, it may be due to presence of other autoantibodies and
disease association which is not included in this antibody profile. When the clinical finding suggests a specific autoimmune disorder, it is
recommended to perform a follow-up test for those antibodies, if commercially available or further Renal Biopsy IFA testing may be considered.
Advised to correlate ancillary investigations and clinical findings.
**End Of Report**
Please visit www.srlworld.com for related Test Information for this accession
Dr.C.N.Srinivas
Vice President – Technical &
Head of HLA & TI
CONDITIONS OF LABORATORY TESTING & REPORTING

1. It is presumed that the test sample belongs to the patient 5. SRL confirms that all tests have been performed or
named or identified in the test requisition form. assayed with highest quality standards, clinical safety &
2. All tests are performed and reported as per the technical integrity.
turnaround time stated in the SRL Directory of Services. 6. Laboratory results should not be interpreted in isolation;
3. Result delays could occur due to unforeseen it must be correlated with clinical information and be
circumstances such as non-availability of kits / equipment interpreted by registered medical practitioners only to
breakdown / natural calamities / technical downtime or any determine final diagnosis.
other unforeseen event. 7. Test results may vary based on time of collection,
4. A requested test might not be performed if: physiological condition of the patient, current medication or
i. Specimen received is insufficient or inappropriate nutritional and dietary changes. Please consult your doctor
ii. Specimen quality is unsatisfactory or call us for any clarification.
iii. Incorrect specimen type 8. Test results cannot be used for Medico legal purposes.
iv. Discrepancy between identification on specimen 9. In case of queries please call customer care
container label and test requisition form (91115 91115) within 48 hours of the report.
.
SRL Limited
Fortis Hospital, Sector 62, Phase VIII,
Mohali 160062
Page 2 Of 2
Scan to View Details Scan to View Report

Diagnostic Report: Final

Uploaded by

Copyright:

Available Formats

Diagnostic Report: Final

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Diagnostic Report: Final

Uploaded by

Copyright:

Available Formats

DIAGNOSTIC REPORT

Patient Ref. No. 323000001124697

CLIENT CODE : C000137711

CLIENT'S NAME AND ADDRESS :

PATIENT NAME : MRS.SHANMUGAPRIYA P PATIENT ID : MRSSF240979323

ACCESSION NO : 0323VI006981 AGE : 43 Years SEX : Female

DRAWN : 24/09/2022 00:00 RECEIVED : 24/09/2022 12:20 REPORTED : 24/09/2022 16:21

REFERRING DOCTOR : DR. DR P RAJA MD CLIENT PATIENT ID :

Test Report Status Final Results Biological Reference Interval Units

EIA - AUTO IMMUNE

ANTI - CCP ANTIBODIES <7.00 < or = 17.00 U/mL

SMITH ANTIBODIES NEGATIVE (0)

Scan to View Details Scan to View Report

CLIENT CODE : C000137711

CLIENT'S NAME AND ADDRESS :

PATIENT NAME : MRS.SHANMUGAPRIYA P PATIENT ID : MRSSF240979323

ACCESSION NO : 0323VI006981 AGE : 43 Years SEX : Female

DRAWN : 24/09/2022 00:00 RECEIVED : 24/09/2022 12:20 REPORTED : 24/09/2022 16:21

REFERRING DOCTOR : DR. DR P RAJA MD CLIENT PATIENT ID :

Test Report Status Final Results Biological Reference Interval Units

ANTI-MI-2 NEGATIVE (0)

CONDITIONS OF LABORATORY TESTING & REPORTING

Scan to View Details Scan to View Report

You might also like